KRISTINE INGRO: Open Payments
NPI 1982028858 · TONAWANDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 20 payments from 8 companies in 2025. Trend: 2023 $964 · 2024 $472 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $162 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| Lundbeck LLC | 2 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
Products named: Auvelity, AUSTEDO XR, REXULTI, INGREZZA, FANAPT, COBENFY, VRAYLAR.
Industry payments across NY — which companies pay providers there.
